497 related articles for article (PubMed ID: 1752350)
1. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
2. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A
Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473
[TBL] [Abstract][Full Text] [Related]
3. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
Reaven GM; Johnston P; Hollenbeck CB; Skowronski R; Zhang JC; Goldfine ID; Chen YD
J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
[TBL] [Abstract][Full Text] [Related]
4. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
5. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
[TBL] [Abstract][Full Text] [Related]
6. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
Elkeles RS
Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
[TBL] [Abstract][Full Text] [Related]
7. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
11. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
Jeppesen J; Zhou MY; Chen YD; Reaven GM
Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
[TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia.
Fedele D; Tiengo A; Nosadini R; Marchiori E; Briani G; Garotti MC; Muggeo M
Diabete Metab; 1976 Sep; 2(3):127-33. PubMed ID: 188698
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
15. Effect of the prostaglandin E1 analog enisoprost on glucose and lipid metabolism in patients with type II diabetes mellitus.
Kasim SE; Moran M; Khilnani S; West MA; Jen KL
Horm Metab Res; 1992 Apr; 24(4):176-80. PubMed ID: 1601393
[TBL] [Abstract][Full Text] [Related]
16. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
[TBL] [Abstract][Full Text] [Related]
18. Metabolic abnormalities following heart transplantation in patients with idiopathic cardiomyopathy.
Sheu WH; Wei J; Jeng CY; Fuh MM; Chen YD
Horm Metab Res; 1995 Oct; 27(10):469-72. PubMed ID: 8575727
[TBL] [Abstract][Full Text] [Related]
19. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
20. Bezafibrate retard in patients with insulin-dependent diabetes: effect on serum lipoproteins, fibrinogen, and glycemic control.
Durrington PN; Winocour PH; Bhatnagar D
J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S30-4. PubMed ID: 1710743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]